INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic...
39 insider purchases on record · latest filing 2024-09-30.
Insiders have also filed 23 sale transactions at INMB.